HuangQi Decoction Ameliorates Renal Fibrosis via TGF-β/Smad Signaling Pathway In Vivo and In Vitro
Objective: Traditional Chinese Medicine compound HuangQi decoction is widely used in clinical treatment of chronic kidney disease, but its role on renal interstitial fibrosis and the underlying mechanism remains unclear. The aim of this study is to investigate the effect of HuangQi decoction on rena...
Main Authors: | Jie Zhao, Li Wang, Ai-li Cao, Ming-Qian Jiang, Xia Chen, Yi Wang, Yun-man Wang, Hao Wang, Xue-Mei Zhang, Wen Peng |
---|---|
Format: | Article |
Language: | English |
Published: |
Cell Physiol Biochem Press GmbH & Co KG
2016-05-01
|
Series: | Cellular Physiology and Biochemistry |
Subjects: | |
Online Access: | http://www.karger.com/Article/FullText/443115 |
Similar Items
-
HuangQi Decoction Improves Renal Tubulointerstitial Fibrosis in Mice by Inhibiting the Up-Regulation of Wnt/β-Catenin Signaling Pathway
by: Ming-Qian Jiang, et al.
Published: (2015-05-01) -
Huangqi Decoction Ameliorates Streptozotocin-Induced Rat Diabetic Nephropathy through Antioxidant and Regulation of the TGF-β/MAPK/PPAR-γ Signaling
by: Haiyan Han, et al.
Published: (2017-08-01) -
Huangqi Shengmai Yin Ameliorates Myocardial Fibrosis by Activating Sirtuin3 and Inhibiting TGF-β/Smad Pathway
by: Jianheng Pan, et al.
Published: (2021-08-01) -
Analysis of the action mechanism of Fang Ji Huang Qi decoction in treating rheumatoid arthritis by network pharmacology
by: Yang Hu, et al.
Published: (2018-11-01) -
Huangqi Fuzheng decoction exerts antitumor activity by inhibiting cell growth and inducing cell death in osteosarcoma
by: Jinghao Qin, et al.
Published: (2019-06-01)